Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Int J Antimicrob Agents. 2018 Jan 11;51(3):468–478. doi: 10.1016/j.ijantimicag.2017.12.032

Table 3.

Reported clinical characteristics and outcomes in patients with native and prosthetic valve endocarditis due to Listeria monocytogenes.

Variable Native Valve
Endocarditis
(n = 51)		 Prosthetic Valve
Endocarditis
(n = 41)
Age, Mean Years (Range) 51 (10 to 83) 68 (27 to 87)
Ratio of Male to Female Patients 1.4 2.2
Site of Cardiac Involvement: (No. of Patients) (No. of Patients)
  Aortic 14 14
  Mitral 12 23
  Tricuspid 3 1
  Aortic + Mitral 14 2
  Aortic + Tricuspid 1 0
  Mitral + Tricuspid 0 1
  Unknown 7 0
Antibiotic Therapy: Proportion of
Patients With
Cure (% Survival)		 Proportion of
Patients With
Cure (% Survival)
  Penicillin or Ampicillin or Amoxicillin Only 9/10 (90%) 2/4 (50%)
  Penicillin or Ampicillin or Amoxicillin + Aminoglycoside 13/22 (59%) 21/26 (77%)
    Penicillin or Ampicillin or Amoxicillin Only and Penicillin or Ampicillin or Amoxicillin + Aminoglycoside 22/32 (69%) 23/30 (77%)
Medical or Medical + Surgical Therapy:
  Medical 24/37 (65%) 17/22 (77%)
  Medical + Surgical 5/9 (56%) 14/17 (82%)
Overall Survival 30/50 (60%) 32/41 (78%)